中成药治疗心律失常的机制及其临床应用

王杨淦, 王俊程, 王艾丽. 中成药治疗心律失常的机制及其临床应用[J]. 临床心血管病杂志, 2024, 40(3): 167-170. doi: 10.13201/j.issn.1001-1439.2024.03.002
引用本文: 王杨淦, 王俊程, 王艾丽. 中成药治疗心律失常的机制及其临床应用[J]. 临床心血管病杂志, 2024, 40(3): 167-170. doi: 10.13201/j.issn.1001-1439.2024.03.002
WANG Yanggan, WANG Juncheng, WANG Aili. Mechanism and clinical application of traditional Chinese medicines in treating arrhythmias[J]. J Clin Cardiol, 2024, 40(3): 167-170. doi: 10.13201/j.issn.1001-1439.2024.03.002
Citation: WANG Yanggan, WANG Juncheng, WANG Aili. Mechanism and clinical application of traditional Chinese medicines in treating arrhythmias[J]. J Clin Cardiol, 2024, 40(3): 167-170. doi: 10.13201/j.issn.1001-1439.2024.03.002

中成药治疗心律失常的机制及其临床应用

详细信息

Mechanism and clinical application of traditional Chinese medicines in treating arrhythmias

More Information
  • 心律失常的治疗目前仍以西药为主,但是西药在抗心律失常的同时也会有一定的致心律失常的风险。中成药在治疗心律失常方面的作用越来越得到重视。研究表明,中成药靶向多个离子通道,对心律失常有着较好的疗效。中成药有可能成为预防和治疗心律失常的有效手段和补充治疗药物,这在临床上得到了一定的验证。本文将对一些中成药治疗心律失常的电生理机制和临床应用进行综述,旨在为心律失常的治疗提供新的思路和方向。
  • 加载中
  • [1]

    Mehra R. Global public health problem of sudden cardiac death[J]. J Electrocardiol, 2007, 40(6 Suppl): S118-122.

    [2]

    Hao PP, Jiang F, Chen YG, et al. Traditional Chinese medication for cardiovascular disease[J]. Nat Rev Cardiol, 2015, 12(6): 318.

    [3]

    Wang X, Wang T, Ding S, et al. Xin Su Ning—A Review of Basic and Clinical Pharmacology Integrated With Traditional Chinese Medicine Antiarrhythmic Theory[J]. Front Pharmacol, 2021, 12: 657484. doi: 10.3389/fphar.2021.657484

    [4]

    Ma YL, Hu RM, Yang X, et al. Investigation of the Cellular Pharmacological Mechanism and Clinical Evidence of the Multi-Herbal Antiarrhythmic Chinese Medicine Xin Su Ning[J]. Front Pharmacol, 2020, 11: 600. doi: 10.3389/fphar.2020.00600

    [5]

    Wang T, Streeter H, Wang X, et al. A Network Pharmacology Study of the Multi-Targeting Profile of an Antiarrhythmic Chinese Medicine Xin Su Ning[J]. Front Pharmacol, 2019, 10: 1138. doi: 10.3389/fphar.2019.01138

    [6]

    Wang T, Lu M, Du Q, et al. An integrated anti-arrhythmic target network of compound Chinese medicine Wenxin Keli revealed by combined machine learning and molecular pathway analysis[J]. Mol BioSyst, 2017, 13(5): 1018-1030. doi: 10.1039/C7MB00003K

    [7]

    Yao Y, Liu Y, Zeng Z, et al. Identification of Target Genes of Antiarrhythmic Traditional Chinese Medicine Wenxin Keli[J]. Cardiovasc Ther, 2020, 2020: 3480276.

    [8]

    徐涛, 陈立锋, 李方江, 等. 稳心颗粒对异丙肾上腺素诱发豚鼠心律失常的电生理影响[J]. 中西医结合心脑血管病杂志, 2010, 8(3): 308-309. doi: 10.3969/j.issn.1672-1349.2010.03.033

    [9]

    Tian G, Sun Y, Liu S, et al. Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview[J]. Front Pharmacol, 2018, 9: 1005. doi: 10.3389/fphar.2018.01005

    [10]

    Burashnikov A, Petroski A, Hu D, et al. Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation[J]. Heart rhythm, 2012, 9(1): 125-131. doi: 10.1016/j.hrthm.2011.08.027

    [11]

    Hu D, Barajas-Martínez H, Burashnikov A, et al. Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis[J]. Int J Cardiol, 2016, 207: 326-334. doi: 10.1016/j.ijcard.2016.01.016

    [12]

    Li X, Tian G, Xu L, et al. Wenxin Keli for the Treatment of Arrhythmia-Systems Pharmacology and In Vivo Pharmacological Assessment[J]. Front Pharmacol, 2021, 12: 704622. doi: 10.3389/fphar.2021.704622

    [13]

    Hou JW, Li W, Guo K, et al. Antiarrhythmic effects and potential mechanism of WenXin KeLi in cardiac Purkinje cells[J]. Heart rhythm, 2016, 13(4): 973-982. doi: 10.1016/j.hrthm.2015.12.023

    [14]

    Luo A, Liu Z, Cao Z, et al. Wenxin Keli diminishes Ca2+overload induced by hypoxia/reoxygenation in cardiomyocytes through inhibiting INaL and ICaL[J]. Pacing Clin Electrophysiol, 2017, 40(12): 1412-1425. doi: 10.1111/pace.13206

    [15]

    Wang X, Wang X, Gu Y, et al. Wenxin Keli attenuates ischemia-induced ventricular arrhythmias in rats: Involvement of L type calcium and transient outward potassium currents[J]. Mol Med Rep, 2013, 7(2): 519-524. doi: 10.3892/mmr.2012.1195

    [16]

    李小威, 黄从新, 范新荣, 等. 稳心颗粒对人超极化激活环核苷酸门控阳离子通道2电生理特性的影响[J]. 中国心脏起搏与心电生理杂志, 2011, 25(3): 249-252. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXZ201103022.htm

    [17]

    Jiang X, Luo Y, Wang X, et al. Investigating the efficiency and tolerability of traditional Chinese formulas combined with antiarrhythmic agents for paroxysmal atrial fibrillation: A systematic review and Bayesian network meta-analysis[J]. Phytomedicine, 2022, 94: 153832. doi: 10.1016/j.phymed.2021.153832

    [18]

    Zheng R, Tian GH, Zhang Q, et al. Clinical Safety and Efficacy of Wenxin Keli-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Systematic Review and Meta-analysis[J]. Front Physiol, 2018, 9: 487. doi: 10.3389/fphys.2018.00487

    [19]

    李宁, 霍有平, 马克娟, 等. 通络药物对心肌细胞钠钙离子通道的影响[J]. 中华医学杂志, 2007, 87(14): 995-998. doi: 10.3760/j:issn:0376-2491.2007.14.016

    [20]

    Yan Z, Zhong L, Zhu W, et al. Chinese herbal medicine for the treatment of cardiovascular diseases-Targeting cardiac ion channels[J]. Pharmacol Res, 2023, 192: 106765. doi: 10.1016/j.phrs.2023.106765

    [21]

    Zhang K, Shi L, Tang HJ, et al. Effect of Shen Song Yang Xin Capsule on Myocardial Electrophysiology of Acute Atrial Fibrillation in Canine Model[J]. Chin Med J, 2017, 130(20): 2513-2514. doi: 10.4103/0366-6999.216404

    [22]

    Wang ZQ, Jiang XJ, Zhang GY, et al. Effects of ginseng-spikenard heart-nourishing capsule on inactivation of C-type Kv1.4 potassium channel[J]. Pak J Pharm Sci, 2016, 29(5): 1513-1517.

    [23]

    Wang X, Hu D, Dang S, et al. Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial[J]. Chin Med J, 2017, 130(14): 1639-1647. doi: 10.4103/0366-6999.209906

    [24]

    Cao X, Zhou M, Liu H, et al. Clinical Efficacy and Safety of Shensong Yangxin Capsule-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Meta-Analysis of Randomized Controlled Trials[J]. Front Pharmacol, 2021, 12: 613922. doi: 10.3389/fphar.2021.613922

    [25]

    Zhang MZ, Yu J, Qu JS, et al. Suxiao Jiuxin Pills, a Chinese herbal complex, block human potassium channel current hKv1.5 in CHO cells[EB/OL]. PREPRINT (Version 1) available at Research Square. doi.org/10.21203/rs.3.rs-1671572/v1

    [26]

    Qi JY, Kang DY, Yu J, et al. Suxiao Jiuxin Pills Prevent Ventricular Fibrillation from Inhibiting L-type Calcium Currents CaV1.2 in vivo and in vitro[J]. Chin J Integr Med, 2023, 29(2): 108-118. doi: 10.1007/s11655-022-3623-7

    [27]

    Piantoni C, Paina M, Molla D, et al. Chinese natural compound decreases pacemaking of rabbit cardiac sinoatrial cells by targeting second messenger regulation of f-channels[J]. ELife, 2022, 11: e75119. doi: 10.7554/eLife.75119

    [28]

    徐柏榕, 邢作英, 王永霞. 通脉养心丸治疗心律失常的研究进展[J]. 中西医结合心脑血管病杂志, 2023, 21(24): 4536-4541. doi: 10.12102/j.issn.1672-1349.2023.24.011

    [29]

    陈善夫, 邓林华, 李梦蕾, 等. 通脉养心丸治疗心律失常疗效的系统评价与Meta分析[J]. 中华中医药学刊, 2020, 38(2): 244-250. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202002061.htm

    [30]

    李傲, 陈克研, 侯平. 钙离子通道在参仙升脉口服液改善老龄大鼠窦房结功能障碍中的表达变化[J]. 中华中医药学刊, 2018, 36(3): 744-747. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201803061.htm

    [31]

    刘越, 刘宁, 李蒙, 等. 参仙升脉口服液调控心率作用机制的研究[J]. 临床心电学杂志, 2017, 26(1): 23-26. doi: 10.3969/j.issn.1005-0272.2017.01.010

    [32]

    Liu ZY, Huang J, Liu NN, et al. Molecular Mechanisms of Increased Heart Rate in Shenxianshengmai-treated Bradycardia Rabbits[J]. Chin Med J, 2017, 130(2): 179-186.

    [33]

    张念强, 顾翔, 蔡敏一. 参仙升脉口服液治疗缓慢性心律失常的研究进展[J]. 中华老年多器官疾病杂志, 2021, 20(3): 233-236. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLQG202103025.htm

    [34]

    胡海殷, 季昭臣, 于丹丹, 等. 中成药治疗缓慢性心律失常临床随机对照试验的网状Meta分析[J]. 中国中药杂志, 2020, 45(5): 1149-1158. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202005027.htm

    [35]

    王晓宇, 胡海殷, 季昭臣, 等. 养心定悸胶囊治疗心律失常的疗效及安全性系统评价及Meta分析[J]. 中国中药杂志, 2021, 46(20): 5418-5427. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202120031.htm

    [36]

    郭建丽, 牛天福, 杨小燕, 等. 二参复脉胶囊对比心宝丸干预老年窦性心动过缓优效性及安全性随机对照双盲试验[J]. 中医杂志, 2021, 62(3): 224-228. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202103010.htm

  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  484
  • 施引文献:  0
出版历程
收稿日期:  2024-02-21
刊出日期:  2024-03-13

返回顶部

目录